Quality Parameters for Flow Cytometric Minimal Residual Disease (MRD) Assessment in Plasma Cell Neoplasms

被引：0
|
作者：
Qureshi, Rashid [1 ]
Otteson, Gregory [2 ]
Timm, Michael [2 ]
Shi, Min [2 ]
Olteanu, Horatiu [2 ]
Kumar, Shaji [2 ]
Jevremovic, Dragan [2 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1451
引用
收藏
页码：1367 / 1368
页数：2
相关论文
共 50 条
  • [21] Application of myeloma plasma cell immunophenotype in the assessment of minimal residual disease
    Rawstron, AC
    Owen, RG
    Child, JA
    Morgan, GJ
    Jack, AS
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 211 - 211
  • [22] Flow Cytometric Analysis of Minimal Residual Disease in Acute Myeloid Leukemia
    Koehenke, T.
    Sauter, D.
    Sauerland, M-C
    Schneider, S.
    Braess, J.
    Hiddemann, W.
    Spiekermann, K.
    Subklewe, M.
    ANNALS OF HEMATOLOGY, 2015, 94 : S30 - S31
  • [23] Flow Cytometric Analysis of Minimal Residual Disease in Acute Myeloid Leukemia
    Koehnke, T.
    Sauter, D.
    Sauerland, M-C.
    Schneider, S.
    Braess, J.
    Hiddemann, W.
    Spiekermann, K.
    Subklewe, M.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 30 - 31
  • [24] Improved measurement of minimal residual disease (MRD).
    Morley, Alexander A.
    Latham, Sue
    Brisco, Michael J.
    Sykes, Pamela J.
    Koss, Bryone
    Waters, Keith
    BLOOD, 2006, 108 (11) : 647A - 647A
  • [25] STUDYING T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) MINIMAL RESIDUAL DISEASE (MRD) USING TEN COLOR FLOW CYTOMETRIC ASSAY
    Rabade, N.
    Ghodke, K.
    Bibi, A.
    Ghogule, S.
    Badrinath, Y.
    Patkar, N.
    Subramanian, P. G.
    Gujral, S.
    Banawali, S.
    Tembhare, P.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S257 - S258
  • [26] Flow cytometry detection of minimal residual disease (MRD) in children treated for AML
    Bjorklund, E
    Porwit-Macdonald, A
    Soderhall, S
    CYTOMETRY PART A, 2004, 59A (01): : 135 - 135
  • [27] Flow cytometric detection of minimal residual disease in acute lymphoblastic leukemia
    Dworzak, MN
    Panzer-Grümayer, ER
    LEUKEMIA & LYMPHOMA, 2003, 44 (09) : 1445 - 1455
  • [28] Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple Myeloma
    Gupta, Ritu
    Bhaskar, Archana
    Kumar, Lalit
    Sharma, Atul
    Jain, Paresh
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) : 728 - 732
  • [29] Modeling minimal residual disease (MRD)-testing
    Butturini, A
    Klein, J
    Gale, RP
    LEUKEMIA RESEARCH, 2003, 27 (04) : 293 - 300
  • [30] ROR-1 Is a Highly Discriminative Marker in Flow Cytometric Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL)
    Patz, Michaela
    Pentok, Barbara
    Cremer, Kathrin
    Linnartz, Stefanie
    Lilienweiss, Esther
    Kleinert, Fanni
    Hallek, Michael
    Kreuzer, Karl-Anton
    BLOOD, 2016, 128 (22)
12345